Immunization News and Research

RSS

Beyond Moose and Mountains initiative focuses on building Canada's business and regulatory environment

At its 2010 annual general meeting in Montreal yesterday, the national biotechnology association, BIOTECanada, confirmed a national team of industry leaders, whose expertise will ensure Canada keeps growing what today is an $84 billion bio-economy.

21 Jun 2010

MN HIE to conduct pilot project with Aging Services of Minnesota

The Minnesota Health Information Exchange (MN HIE) will conduct a pilot project with Aging Services of Minnesota at 12 of their member settings. This select group of care centers and assisted-living providers will use MN HIE's stand alone web services to view long term care patient's clinical information.

19 Jun 2010

USAID pledges $1.2M in support for national polio vaccination campaigns across Central Asia

The United States Agency for International Development has pledged $1.2 million in support for national poliomyelitis vaccination campaigns across Central Asia to fight the first outbreak of polio in the region since 2002.

19 Jun 2010

SAHM strongly recommends HPV vaccines for males

On May 28, 2010, the Advisory Committee on Immunization Practices published its guidance for use of the quadrivalent HPV vaccine in males. While noting that the vaccine was approved by the FDA for use in males ages 9 through 26 to reduce their likelihood of acquiring genital warts and that it therefore could be given for this purpose, the statement released by ACIP did not recommend routine HPV vaccination of males.

19 Jun 2010

New polio strategy builds on 99% drop in Nigeria cases but faces 50% funding shortfall

In Geneva this Friday, a broad range of stakeholders will formally launch the new Strategic Plan 2010-2012 for eradicating wild poliovirus.

18 Jun 2010

Stony Brook team creates live attenuated influenza virus vaccine by computer-aided rational design

A team of molecular biologists and computer scientists at Stony Brook University have used a novel method to weaken (attenuate) influenza virus by way of designing hundreds of mutations to its genetic code to create an effective vaccine. Reported online and in the July issue of Nature Biotechnology, the method may be a major step in developing more effective and safe vaccines against influenza, which claims 250,000 to 500,000 lives annually worldwide, partly because existing vaccines are not fully effective.

17 Jun 2010

Wednesday's OpEds: Berwick nomination; Health reform costs and benefits; Medicaid and COBRA in jobs bill

As its real costs become clearer, Obama's program is looking even more expensive for employers, seniors, and taxpayers (Rick Santorum, 6/16).

17 Jun 2010

Microneedle skin patches as effective as hypodermic needles for flu vaccination

Flu vaccine delivered through skin patches containing microneedles has proven at least as effective at preventing influenza in mice as intramuscular, hypodermic flu immunization.

16 Jun 2010

Inovio commences immunization in U.S. Phase I clinical trial of SynCon H5N1 influenza DNA vaccine

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that it has immunized its first subject in a U.S. Phase I clinical trial to evaluate its SynCon™ H5N1 (avian) influenza DNA vaccine, VGX-3400X.

15 Jun 2010

Researchers transform yellow fever vaccine to fend off mosquito borne parasites that cause malaria

There is no vaccine for malaria, which sickens almost a quarter of a billion people each year and kills a child every 30 seconds. That could be changing: researchers at The Rockefeller University have genetically transformed the yellow fever vaccine to prime the immune system to fend off the mosquito borne parasites that cause the disease.

14 Jun 2010

ACIP's new immunization guidelines for upcoming year

Summer is all about barbeques and lazy days at the pool. It's also a good time to start thinking about preparing for flu season, and the vaccinations you or your child may need for the upcoming year, says Carrie Maffeo, a professor of pharmacy at Butler University, who specializes in immunizations.

14 Jun 2010

BIOTECanada congratulates CPHA on 100 years of leadership in public health

As a community partner of the Canadian Public Health Association, BIOTECanada, on behalf of Canada's biotechnology industry, congratulates the CPHA on 100 years of leadership in public health.

11 Jun 2010

sanofi pasteur congratulates Canadian Public Health Association for 100 years of leadership and service

As a longstanding partner in Canada's public health system, sanofi pasteur congratulates the Canadian Public Health Association (CPHA) for their 100 years of leadership and service to our country's public health.

11 Jun 2010

Immunosignature technique provides pre-symptomatic diagnosis for broad range of ailments

An inexpensive system for earlier disease diagnosis could save innumerable lives. It would also have a profound impact on the nation's healthcare industry, currently buckling under the strain of spiraling costs.

9 Jun 2010

Health Canada approves Novartis' Menveo for prevention of meningococcal disease

Novartis Pharmaceutical Canada Inc. announced that Menveo (Meningococcal (Groups A, C, Y and W-135) Oligosaccharide CRM197 Conjugate Vaccine), a quadrivalent meningococcal conjugate vaccine was approved by Health Canada for active immunization of adolescents (11 to 18 years of age) and adults (19 to 55 years of age) to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y and W-135.

8 Jun 2010

BMJ report questions WHO advisors' ties to pharmaceutical industry

"Key scientists behind World Health Organization advice on stockpiling of pandemic flu drugs had financial ties with companies which stood to profit," according to a joint investigation by BMJ in collaboration with the Bureau of Investigative Journalism, BBC News reports (6/4).

5 Jun 2010

Barriers, misinformation still prevent many from seeking flu protection for their families: Canadian Flu Report

According to the Canadian Flu Report released today, 40 per cent of parents are now more interested in vaccinating themselves and their children against seasonal flu following last year's H1N1 outbreak. Yet, significant barriers and misinformation are still preventing many from actually seeking proper flu protection for their families.

2 Jun 2010

Plans to continue flu vaccination ban – intensive investigations ongoing

In the first quarter of this year nearly 300 children across Australia fell ill with fevers, vomiting and convulsions following administration of the seasonal flu vaccine.

2 Jun 2010

New report shows one in three young women receive HPV vaccine to prevent cervical cancer

Only about one in three young women has received the human papillomavirus vaccine to help prevent cervical cancer, according to a new report from researchers at Washington University School of Medicine in St. Louis.

2 Jun 2010

Previous recommendations on H1N1 pandemic influenza vaccine still stand: SAGE

Previous recommendations on who should be vaccinated with the H1N1 pandemic influenza vaccine still stand according to the World WHO's Strategic Advisory Group of Experts on Immunization, the principal advisory group to WHO for development of policy related to vaccines and immunization.

28 May 2010

Immunization News and Research

Beyond Moose and Mountains initiative focuses on building Canada's business and regulatory environment

MN HIE to conduct pilot project with Aging Services of Minnesota

USAID pledges $1.2M in support for national polio vaccination campaigns across Central Asia

SAHM strongly recommends HPV vaccines for males

New polio strategy builds on 99% drop in Nigeria cases but faces 50% funding shortfall

Stony Brook team creates live attenuated influenza virus vaccine by computer-aided rational design

Wednesday's OpEds: Berwick nomination; Health reform costs and benefits; Medicaid and COBRA in jobs bill

Microneedle skin patches as effective as hypodermic needles for flu vaccination

Inovio commences immunization in U.S. Phase I clinical trial of SynCon H5N1 influenza DNA vaccine

Researchers transform yellow fever vaccine to fend off mosquito borne parasites that cause malaria

ACIP's new immunization guidelines for upcoming year

BIOTECanada congratulates CPHA on 100 years of leadership in public health

sanofi pasteur congratulates Canadian Public Health Association for 100 years of leadership and service

Immunosignature technique provides pre-symptomatic diagnosis for broad range of ailments

Health Canada approves Novartis' Menveo for prevention of meningococcal disease

BMJ report questions WHO advisors' ties to pharmaceutical industry

Barriers, misinformation still prevent many from seeking flu protection for their families: Canadian Flu Report

Plans to continue flu vaccination ban – intensive investigations ongoing

New report shows one in three young women receive HPV vaccine to prevent cervical cancer

Previous recommendations on H1N1 pandemic influenza vaccine still stand: SAGE

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News